Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1987 Jan;90(1):99–109. doi: 10.1111/j.1476-5381.1987.tb16829.x

[3H]-verapamil binding to rat cardiac sarcolemmal membrane fragments; an effect of ischaemia.

J S Dillon, W G Nayler
PMCID: PMC1917274  PMID: 3028561

Abstract

The [3H]-verapamil binding activity of rat cardiac sarcolemmal fragments was studied, using membranes harvested from non-perfused, aerobically-perfused and ischaemic hearts. Glass-fibre filters were found to contain specific, high affinity--(KD 38 +/- 3.1 nM) [3H]-verapamil binding sites--making them unsuitable for use in [3H]-verapamil binding studies. Incubation of membranes from non-perfused hearts in a medium containing 150 mM NaCl, 1 mM CaCl2 and 50 mM Tris revealed two populations of [3H]-verapamil binding sites. When centrifugation instead of filtration was used to separate bound and free [3H]-verapamil, high affinity sites with a KD of 0.57 +/- 0.19 microM and a Bmax of 38 +/- 5.2 pmol mg-1 protein, and low affinity sites with a KD of 78 +/- 27.5 microM and a Bmax of 2.9 +/- 1.3 nmol mg-1 protein were detected. However, only low affinity binding sites could be detected in membranes which had been incubated in a cation-free medium containing 50 mM Tris. [3H]-verapamil binding to the low and high affinity sites was saturable, reversible, stereospecific and displaceable by D600 greater than diltiazem greater than Ca2+ but not by nifedipine, nitrendipine, nisoldipine or prazosin. The two populations of binding sites survived aerobic perfusion and 60 min ischaemia at 37 degrees C. Ischaemia reduced the Bmax and KD but selectivity was maintained.

Full text

PDF
99

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bellemann P., Ferry D., Lübbecke F., Glossman H. [3H]-Nitrendipine, a potent calcium antagonist, binds with high affinity to cardiac membranes. Arzneimittelforschung. 1981;31(12):2064–2067. [PubMed] [Google Scholar]
  2. Bellemann P., Ferry D., Lübbecke F., Glossmann H. [3H]-Nimodipine and [3H]-nitrendipine as tools to directly identify the sites of action of 1,4-dihydropyridine calcium antagonists in guinea-pig tissues. Tissue-specific effects of anions and ionic strength. Arzneimittelforschung. 1982;32(4):361–363. [PubMed] [Google Scholar]
  3. Bellemann P., Schade A., Towart R. Dihydropyridine receptor in rat brain labeled with [3H]nimodipine. Proc Natl Acad Sci U S A. 1983 Apr;80(8):2356–2360. doi: 10.1073/pnas.80.8.2356. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bolger G. T., Gengo P., Klockowski R., Luchowski E., Siegel H., Janis R. A., Triggle A. M., Triggle D. J. Characterization of binding of the Ca++ channel antagonist, [3H]nitrendipine, to guinea-pig ileal smooth muscle. J Pharmacol Exp Ther. 1983 May;225(2):291–309. [PubMed] [Google Scholar]
  5. COOPERSTEIN S. J., LAZAROW A., KURFESS N. J. A microspectrophotometric method for the determination of succinic dehydrogenase. J Biol Chem. 1950 Sep;186(1):129–139. [PubMed] [Google Scholar]
  6. Cavey D., Vincent J. P., Làzdunski M. The muscarinic receptor of heart cell membranes. Association with agonists, antagonists and antiarrhythmic agents. FEBS Lett. 1977 Dec 1;84(1):110–114. doi: 10.1016/0014-5793(77)81068-5. [DOI] [PubMed] [Google Scholar]
  7. Corr P. B., Shayman J. A., Kramer J. B., Kipnis R. J. Increased alpha-adrenergic receptors in ischemic cat myocardium. A potential mediator of electrophysiological derangements. J Clin Invest. 1981 Apr;67(4):1232–1236. doi: 10.1172/JCI110139. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Daly M. J., Elz J. S., Nayler W. G. Sarcolemmal enzymes and Na+ -Ca2+ exchange in hypoxic, ischemic, and reperfused rat hearts. Am J Physiol. 1984 Aug;247(2 Pt 2):H237–H243. doi: 10.1152/ajpheart.1984.247.2.H237. [DOI] [PubMed] [Google Scholar]
  9. DePover A., Matlib M. A., Lee S. W., Dubé G. P., Grupp I. L., Grupp G., Schwartz A. Specific binding of [3H]nitrendipine to membranes from coronary arteries and heart in relation to pharmacological effects. Paradoxical stimulation by diltiazem. Biochem Biophys Res Commun. 1982 Sep 16;108(1):110–117. doi: 10.1016/0006-291x(82)91838-1. [DOI] [PubMed] [Google Scholar]
  10. Edwards M. J., Maguire M. H. Purification and properties of rat heart 5'-nucleotidase. Mol Pharmacol. 1970 Nov;6(6):641–648. [PubMed] [Google Scholar]
  11. Ehlert F. J., Roeske W. R., Itoga E., Yamamura H. I. The binding of [3H]nitrendipine to receptors for calcium channel antagonists in the heart, cerebral cortex, and ileum of rats. Life Sci. 1982 Jun 21;30(25):2191–2202. doi: 10.1016/0024-3205(82)90293-4. [DOI] [PubMed] [Google Scholar]
  12. Fairhurst A. S., Whittaker M. L., Ehlert F. J. Interactions of D600 (methoxyverapamil) and local anesthetics with rat brain alpha-adrenergic and muscarinic receptors. Biochem Pharmacol. 1980 Feb;29(2):155–162. doi: 10.1016/0006-2952(80)90323-8. [DOI] [PubMed] [Google Scholar]
  13. Ferry D. R., Glossmann H. Evidence of multiple receptor sites within the putative calcium channel. Naunyn Schmiedebergs Arch Pharmacol. 1982 Oct;321(1):80–83. doi: 10.1007/BF00586355. [DOI] [PubMed] [Google Scholar]
  14. Fosset M., Jaimovich E., Delpont E., Lazdunski M. [3H]nitrendipine receptors in skeletal muscle. J Biol Chem. 1983 May 25;258(10):6086–6092. [PubMed] [Google Scholar]
  15. Galizzi J. P., Fosset M., Lazdunski M. Properties of receptors for the Ca2+-channel blocker verapamil in transverse-tubule membranes of skeletal muscle. Stereospecificity, effect of Ca2+ and other inorganic cations, evidence for two categories of sites and effect of nucleoside triphosphates. Eur J Biochem. 1984 Oct 15;144(2):211–215. doi: 10.1111/j.1432-1033.1984.tb08451.x. [DOI] [PubMed] [Google Scholar]
  16. Galizzi J. P., Fosset M., Lazdunski M. [3H] verapamil binding sites in skeletal muscle transverse tubule membranes. Biochem Biophys Res Commun. 1984 Jan 13;118(1):239–245. doi: 10.1016/0006-291x(84)91092-1. [DOI] [PubMed] [Google Scholar]
  17. Garcia M. L., Trumble M. J., Reuben J. P., Kaczorowski G. J. Characterization of verapamil binding sites in cardiac membrane vesicles. J Biol Chem. 1984 Dec 25;259(24):15013–15016. [PubMed] [Google Scholar]
  18. Glossmann H., Ferry D. R., Goll A., Rombusch M. Molecular pharmacology of the calcium channel: evidence for subtypes, multiple drug-receptor sites, channel subunits, and the development of a radioiodinated 1,4-dihydropyridine calcium channel label, [125I]iodipine. J Cardiovasc Pharmacol. 1984;6 (Suppl 4):S608–S621. [PubMed] [Google Scholar]
  19. Gould R. J., Murphy K. M., Snyder S. H. [3H]nitrendipine-labeled calcium channels discriminate inorganic calcium agonists and antagonists. Proc Natl Acad Sci U S A. 1982 Jun;79(11):3656–3660. doi: 10.1073/pnas.79.11.3656. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Holck M., Thorens S., Haeusler G. Characterization of [3H]nifedipine binding sites in rabbit myocardium. Eur J Pharmacol. 1982 Dec 3;85(3-4):305–315. doi: 10.1016/0014-2999(82)90217-5. [DOI] [PubMed] [Google Scholar]
  21. Holck M., Thorens S., Haeusler G. Does [3H]nifedipine label the calcium channel in rabbit myocardium? J Recept Res. 1983;3(1-2):191–198. doi: 10.3109/10799898309041933. [DOI] [PubMed] [Google Scholar]
  22. Hulthén U. L., Landmann R., Bürgisser E., Bühler F. R. High-affinity binding sites for [3H] verapamil in cardiac membranes. J Cardiovasc Pharmacol. 1982;4 (Suppl 3):S291–S293. [PubMed] [Google Scholar]
  23. Janis R. A., Maurer S. C., Sarmiento J. G., Bolger G. T., Triggle D. J. Binding of [3H]nimodipine to cardiac and smooth muscle membranes. Eur J Pharmacol. 1982 Aug 27;82(3-4):191–194. doi: 10.1016/0014-2999(82)90511-8. [DOI] [PubMed] [Google Scholar]
  24. Janis R. A., Scriabine A. Sites of action of Ca2+ channel inhibitors. Biochem Pharmacol. 1983 Dec 1;32(23):3499–3507. doi: 10.1016/0006-2952(83)90295-2. [DOI] [PubMed] [Google Scholar]
  25. Karliner J. S., Motulsky H. J., Dunlap J., Brown J. H., Insel P. A. Verapamil competitively inhibits alpha 1-adrenergic and muscarinic but not beta-adrenergic receptors in rat myocardium. J Cardiovasc Pharmacol. 1982 May-Jun;4(3):515–520. doi: 10.1097/00005344-198205000-00025. [DOI] [PubMed] [Google Scholar]
  26. Kass R. S., Tsien R. W. Multiple effects of calcium antagonists on plateau currents in cardiac Purkinje fibers. J Gen Physiol. 1975 Aug;66(2):169–192. doi: 10.1085/jgp.66.2.169. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Kohlhardt M., Krause H., Kübler M., Herdey A. Kinetics of inactivation and recovery of the slow inward current in the mammalian ventricular myocardium. Pflugers Arch. 1975 Mar 22;355(1):1–17. doi: 10.1007/BF00584795. [DOI] [PubMed] [Google Scholar]
  28. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  29. Lee K. S., Tsien R. W. Mechanism of calcium channel blockade by verapamil, D600, diltiazem and nitrendipine in single dialysed heart cells. Nature. 1983 Apr 28;302(5911):790–794. doi: 10.1038/302790a0. [DOI] [PubMed] [Google Scholar]
  30. McPherson G. A. A practical computer-based approach to the analysis of radioligand binding experiments. Comput Programs Biomed. 1983 Aug-Oct;17(1-2):107–113. doi: 10.1016/0010-468x(83)90031-4. [DOI] [PubMed] [Google Scholar]
  31. Mukherjee A., Wong T. M., Buja L. M., Lefkowitz R. J., Willerson J. T. Beta adrenergic and muscarinic cholinergic receptors in canine myocardium. Effects of ischemia. J Clin Invest. 1979 Nov;64(5):1423–1428. doi: 10.1172/JCI109600. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Munson P. J., Rodbard D. Ligand: a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem. 1980 Sep 1;107(1):220–239. doi: 10.1016/0003-2697(80)90515-1. [DOI] [PubMed] [Google Scholar]
  33. Murphy K. M., Snyder S. H. Calcium antagonist receptor binding sites labeled with [3H]nitrendipine. Eur J Pharmacol. 1982 Jan 22;77(2-3):201–202. doi: 10.1016/0014-2999(82)90021-8. [DOI] [PubMed] [Google Scholar]
  34. Nayler W. G., Dillon J. S., Elz J. S., McKelvie M. An effect of ischemia on myocardial dihydropyridine binding sites. Eur J Pharmacol. 1985 Sep 10;115(1):81–89. doi: 10.1016/0014-2999(85)90587-4. [DOI] [PubMed] [Google Scholar]
  35. Nayler W. G., Perry S. E., Elz J. S., Daly M. J. Calcium, sodium, and the calcium paradox. Circ Res. 1984 Aug;55(2):227–237. doi: 10.1161/01.res.55.2.227. [DOI] [PubMed] [Google Scholar]
  36. Nayler W. G., Thompson J. E., Jarrott B. The interaction of calcium antagonists (slow channel blockers) with myocardial alpha adrenoceptors. J Mol Cell Cardiol. 1982 Mar;14(3):185–188. doi: 10.1016/0022-2828(82)90118-3. [DOI] [PubMed] [Google Scholar]
  37. Reynolds I. J., Gould R. J., Snyder S. H. [3H]Verapamil binding sites in brain and skeletal muscle: regulation by calcium. Eur J Pharmacol. 1983 Nov 25;95(3-4):319–321. doi: 10.1016/0014-2999(83)90655-6. [DOI] [PubMed] [Google Scholar]
  38. Sarmiento J. G., Janis R. A., Colvin R. A., Triggle D. J., Katz A. M. Binding of the calcium channel blocker nitrendipine to its receptor in purified sarcolemma from canine cardiac ventricle. J Mol Cell Cardiol. 1983 Feb;15(2):135–137. doi: 10.1016/0022-2828(83)90289-4. [DOI] [PubMed] [Google Scholar]
  39. Schwartz A., Triggle D. J. Cellular action of calcium channel blocking drugs. Annu Rev Med. 1984;35:325–339. doi: 10.1146/annurev.me.35.020184.001545. [DOI] [PubMed] [Google Scholar]
  40. Smith H. J., Goldstein R. A., Griffith J. M., Kent K. M., Epstein S. E. Regional contractility. Selective depression of ischemic myocardium by verapamil. Circulation. 1976 Oct;54(4):629–635. doi: 10.1161/01.cir.54.4.629. [DOI] [PubMed] [Google Scholar]
  41. Striessnig J., Zernig G., Glossmann H. Ca2+ antagonist receptor sites on human red blood cell membranes. Eur J Pharmacol. 1985 Feb 5;108(3):329–330. doi: 10.1016/0014-2999(85)90460-1. [DOI] [PubMed] [Google Scholar]
  42. WARREN L. The thiobarbituric acid assay of sialic acids. J Biol Chem. 1959 Aug;234(8):1971–1975. [PubMed] [Google Scholar]
  43. Williams L. T., Tremble P. Binding of a calcium antagonist, [3H]nitrendipine, to high affinity sites in bovine aortic smooth muscle and canine cardiac membranes. J Clin Invest. 1982 Jul;70(1):209–212. doi: 10.1172/JCI110596. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES